Kalohexis, LLC· @kalohexis · X·· 2026-04-18Score60
Body · original
Attending #AACR26? Stop by Poster Section 51 on April 21 to learn more about the study design of the ongoing Phase 2 Paradox trial evaluating mifomelatide for #cachexia in patients with advanced colorectal #cancer. More details here:
https://
bit.ly/41FzwsY
Heat 0 · 0 likes · 0 replies · 0 reposts
Source: Kalohexis, LLC · x.com
